Futa Koga

机构：Saga Medical School Hospital, Saga-Ken Medical Centre Koseikan

发表论文 60 篇 · 总被引 256 次 · h-index 11

代表论文

• A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study (2021 · International Journal of Clinical Oncology · 被引 26)
• Gemcitabine plus nab-paclitaxel in older patients with metastatic pancreatic cancer: A post-hoc analysis of the real-world data of a multicenter study (the NAPOLEON study) (2021 · Journal of Geriatric Oncology · 被引 23)
• C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel (2023 · Scientific Reports · 被引 19)
• Efficacy of second-line chemotherapy after treatment with gemcitabine plus nab-paclitaxel or FOLFIRINOX in patients with metastatic pancreatic cancer (2023 · Scientific Reports · 被引 18)
• Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab–paclitaxel or FOLFIRINOX: A post–hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study) (2022 · BMC Cancer · 被引 17)
• A multicenter retrospective observational NAPOLEON2 study of nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable pancreatic cancer (2024 · Scientific Reports · 被引 13)